NCT06415643

The Use of Islet Organoids in the Treatment of Pancreatic Surgery-related Diabetes

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 5 (estimated)
• Sponsor: Zhejiang University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this clinical trial is to verify the safety and effectiveness of autologous islet organoids transplantation after in vitro expansion for the treatment of pancreatogenic diabetes.

Detailed description

The purpose of this clinical trial is to verify the safety and effectiveness of autologous islet transplantation after in vitro expansion in the forms of functional islet organoids, for the treatment of pancreatogenic diabetes in participants who have undergone pancreatic resection through a single-center single-arm study. The investigators aim to establish the entire operational process of isolating expanding and transplanting islets from the pancreas removed from the participants and managing postoperative care. The investigators hope to accumulate clinical experience in treating pancreatogenic diabetes with transplanted autologous islet cell clusters expanded in vitro establish standard and regulated medical operations and gather materials for future applications of this treatment method in clinical practice.

Conditions

• T3c Diabetes

Interventions

Type	Name	Description
OTHER	Islet organoids transplantation	autologous transplantation of ex vivo expanded islet organoids.

Timeline

• Start date: 2024-08-10
• Primary completion: 2025-12-31
• Completion: 2026-12-31
• First posted: 2024-05-16
• Last updated: 2024-07-30

Locations

1 site across 1 country: China